BNP Paribas Arbitrage SA Purchases 1,809 Shares of The Advisory Board Co. (ABCO)
BNP Paribas Arbitrage SA boosted its position in The Advisory Board Co. (NASDAQ:ABCO) by 111.7% during the third quarter, Holdings Channel reports. The institutional investor owned 3,428 shares of the company’s stock after buying an additional 1,809 shares during the period. BNP Paribas Arbitrage SA’s holdings in The Advisory Board were worth $153,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in ABCO. BlackRock Inc. raised its position in The Advisory Board by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock worth $116,000 after buying an additional 455 shares during the last quarter. Teacher Retirement System of Texas raised its stake in The Advisory Board by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 5,856 shares of the company’s stock valued at $207,000 after buying an additional 708 shares in the last quarter. Champlain Investment Partners LLC raised its stake in The Advisory Board by 26.6% in the first quarter. Champlain Investment Partners LLC now owns 6,950 shares of the company’s stock valued at $224,000 after buying an additional 1,460 shares in the last quarter. Princeton Alpha Management LP acquired a new stake in The Advisory Board during the second quarter valued at about $236,000. Finally, Raymond James & Associates raised its stake in The Advisory Board by 0.4% in the second quarter. Raymond James & Associates now owns 7,067 shares of the company’s stock valued at $250,000 after buying an additional 28 shares in the last quarter.
The Advisory Board Co. (NASDAQ:ABCO) opened at 42.58 on Monday. The company’s 50-day moving average price is $42.95 and its 200-day moving average price is $36.92. The Advisory Board Co. has a one year low of $18.87 and a one year high of $54.84. The stock’s market cap is $1.71 billion.
The Advisory Board (NASDAQ:ABCO) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.34 by $0.13. The Advisory Board had a positive return on equity of 11.59% and a negative net margin of 10.21%. The business earned $198.40 million during the quarter, compared to analyst estimates of $196.49 million. During the same quarter in the prior year, the business posted $0.40 EPS. The Advisory Board’s revenue for the quarter was up 7.4% compared to the same quarter last year. Analysts forecast that The Advisory Board Co. will post $1.86 EPS for the current fiscal year.
ABCO has been the subject of several research analyst reports. Credit Suisse Group AG reissued a “buy” rating and set a $50.00 price objective on shares of The Advisory Board in a research note on Friday, September 16th. Barclays PLC lifted their price objective on The Advisory Board from $44.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, September 30th. Raymond James Financial Inc. lowered The Advisory Board from an “outperform” rating to a “market perform” rating in a research note on Tuesday, July 19th. William Blair reissued an “outperform” rating on shares of The Advisory Board in a research note on Tuesday, September 27th. Finally, Cantor Fitzgerald reissued a “hold” rating on shares of The Advisory Board in a research note on Friday, August 19th. Five research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The Advisory Board has a consensus rating of “Buy” and an average price target of $44.07.
In other The Advisory Board news, Director Leanne M. Zumwalt sold 2,736 shares of the stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $41.70, for a total transaction of $114,091.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Evan R. Farber sold 2,924 shares of the stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $40.95, for a total transaction of $119,737.80. The disclosure for this sale can be found here. Company insiders own 2.90% of the company’s stock.
The Advisory Board Company Profile
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.
Want to see what other hedge funds are holding ABCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Advisory Board Co. (NASDAQ:ABCO).
Receive News & Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related companies with MarketBeat.com's FREE daily email newsletter.